Effect pf probiotic Biolactic G-500 on biochemical indicators of blood of calves with non-specific bronchopneumonia-Reference-Cited by-同舟云学术

Effect pf probiotic Biolactic G-500 on biochemical indicators of blood of calves with non-specific bronchopneumonia

Published:2023-07-19 Issue:2 Volume: Page:63-66
ISSN:2782-6252
Container-title:Legal regulation in veterinary medicine
language:
Short-container-title:jour

Author:

Pogranovsky S. N.¹,Prusakov A. V.¹,Yashin A. V.¹

Affiliation:

1. St. Petersburg State University of Veterinary Medicine

Abstract

The aim of the study was to establish the degree of influence of the Biolatic G–500 probiotic on the biochemical parameters of the blood of calves with nonspecific bronchopneumonia. The object of the study is calves of a black–and-white Holstein breed aged 20-30 days. Groups of animals were formed as they were born and became ill. The first (control) – intact – group (n=10) was formed from clinically healthy animals. The second (n=10) and third (n=10) experimental groups included animals with nonspecific catarrhal bronchopneumonia. The animals of the second group received a typical treatment regimen, including: a single subcutaneous injection of the antibiotic "Pulmovet" at a dose of 1.0 ml per 40.0 kg of body weight; intramuscular injection of the antibiotic "Florox" at a dose of 1.0 ml per 15.0 kg of body weight with an interval of 48 hours before recovery; with an increase in body temperature, "Ketoprofen 10%" at a dose of 3.0 mg per 1.0 kg of body weight, once a day before its normalization; with severe shortness of breath, a single intramuscular injection of Dexamethasone at a dose of 2.0 ml per head. Animals of the third group were additionally prescribed the probiotic drug "Biolatic" (Biolatic) G-500 at a dose of 10.0 g per day per head. It was found that the use of Biolatic G-500 probiotic in the treatment regimen of nonspecific catarrhal bronchopneumonia of young animals contributes to the acceleration of normalization of the biochemical status of animals. This is evidenced by the dynamics of the digital values of its main indicators, in comparison with intact animals and animals whose treatment regimen did not include this drug.

Publisher

Saint-Petersburg State University of Veterinary Medicine

Reference6 articles.

1. Prusakov, A.V. Clinical and hematological status of healthy and bronchopneumonic lambs / A.V. Prusakov, G. V. Kulyakov, A.V. Yashin, P. S. Kiselenko // Hippology and veterinary medicine. – 2021. – № 1(39). – P. 147-152.

2. Yashin, A.V. The effect of repeated aerosol administration of dicloxacillin on some immunobiochemical parameters of calves' blood / A.V. Yashin, P. S. Kiselenko // Hippology and veterinary medicine. – 2013. – № 3(9). – Pp. 135-137.

3. Yashin, A.V. Assessment of the clinical condition of animals and the use of drugs in diseases of the digestive system / A.V. Yashin, G. V. Kulyakov, G. G. Shcherbakov [et al.]. – Saratov : Publishing House "Saratov source", 2019. – 160 p.

4. Shavrov, S. S. The use of probiotic drugs in the treatment of nonspecific dyspepsia / S. S. Shavrov, A.V. Prusakov // Knowledge of young people for the development of veterinary medicine and agriculture of the country : Materials of the X anniversary international scientific conference of students, postgraduates and young scientists dedicated to the Year of Science and technology, St. Petersburg, November 23-24, 2021. – St. Petersburg: St. Petersburg State University of Veterinary Medicine, 2021. – pp. 391-392.

5. Kalugniy I. I. Diagnosis of hepatopathy in Holstein cattle with metabolic disorders / I. I. Kalugniy, D. S. Markova, A. V. Yashin [et al.] // IOP conference series: earth and environmental science : Agriculture, field cultivation, animal husbandry, forestry and agricultural products Сер. 2, Smolensk, 25 января 2021 года. Vol. 723. – Smolensk, 2021. – P. 022029.